RecruitingNCT07216989
Fastomics: Metabolic and Therapeutic Effects of Prolonged Fasting
Sponsor
University of Minnesota
Enrollment
15 participants
Start Date
Aug 5, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This is an observational study investigating how the metabolic and cell marker changes in Prolonged Fasting in the serum may be used against a cell-based model of disease for therapeutic purposes.
Eligibility
Min Age: 18 YearsMax Age: 65 Years
Inclusion Criteria5
- Ages of 18-65 years old
- Not pregnant
- No comorbid conditions
- BMI of 18.5-29.9.
- Has a smartphone
Exclusion Criteria5
- Concern for active eating disorder per screening questionnaire
- Self-reported eating disorder or history of eating disorder
- History of hypoglycemia or contraindication for Prolonged Fasting
- Weight <120lbs
- History of blood donation within the last 3 months.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERFasting
fast with water for up to 60 hours while wearing continuous glucose monitors
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07216989
Related Trials
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
NCT0675104319 locations
Study of the Effect of Innate on the Inflammatory Response to Endotoxin
NCT011434801 location
Exercise Effects on Adipose Tissue Structure and Function
NCT048123141 location
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
NCT060074041 location
The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV
NCT072261281 location